Percentage of Participants With an Occurrence of Biopsy Proven Acute Rejection (BPAR) During the First 3 Months Post de Novo Liver Transplantation. [clinicaltrials_resource:NCT00149994/outcome/1]

Percentage of Participants With an Occurrence of Biopsy Proven Acute Rejection (BPAR) During the First 3 Months Post de Novo Liver Transplantation. [clinicaltrials_resource:NCT00149994/outcome/1]

Outcome [clinicaltrials_vocabulary:Outcome]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:NCT00149994/outcome/1

Percentage of Participants With an Occurrence of Biopsy Proven Acute Rejection (BPAR) During the First 3 Months Post de Novo Liver Transplantation. [clinicaltrials_resource:NCT00149994/outcome/1]

Outcome [clinicaltrials_vocabulary:Outcome]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:NCT00149994/outcome/1
Bio2RDF identifier
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00149994/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Intention to treat (ITT) population.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Participants Wit ...... de Novo Liver Transplantation.
@en
identifier
clinicaltrials_resource:NCT00149994/outcome/1
title
A BPAR is defined when the inv ...... roven rejections) at 3 months.
@en
inDataset
type
label
Percentage of Participants Wit ...... esource:NCT00149994/outcome/1]
@en